Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 2 3Phase 3 2Phase NA 1Phase 2/3 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Vomiting 6Neoplasms 4Nausea 3Lymphoma 1Leukemia 1Breast Neoplasms 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Palonosetron × Clear all
NCT02532634 2018-05-11

RAPA

Kangdong Sacred Heart Hospital

Phase 4 Completed
292 enrolled

Neoplasms, Vomiting

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 4 Completed
59 enrolled

Nausea, Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Merck Sharp & Dohme LLC

Phase 4 Completed
118 enrolled

Nausea, Neoplasms, Vomiting

NCT01481831 2012-12-31

ESPNV

Shanghai Changzheng Hospital

Phase 4 Completed
599 enrolled

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡